{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:03:17Z","timestamp":1790827397324,"version":"4.1.0"},"reference-count":47,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T00:00:00Z","timestamp":1181001600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thiazolidinediones, also known as glitazones, represent a relatively new class of medication used for glycemic control in patients with type II diabetes mellitus. These drugs interact with the peroxisome proliferator\u2010activated receptor \u03b3, a member of the nuclear receptor superfamily, which in turn heterodimerizes with retinoid X receptors to stimulate gene transcription. At a physiologic level, glitazones stimulate adipocyte differentiation, enhance insulin\u2010sensitive glucose uptake by muscle and fat cells, suppress angiogenesis, inhibit tumor cell growth, and normalize keratinocyte differentiation. They have also demonstrated the capacity to diminish inflammatory cytokine production, most notably, that of tumor necrosis factor \u03b1. Patients with such disparate conditions as psoriasis, hirsutism, melanoma, angiosarcoma, lipodystrophy, and necrobiosis lipoidica have benefited from the administration of thiazolidinediones. Clinicians should become familiar with glitazones as they are experiencing a burgeoning use among patients with non\u2010insulin\u2010dependent diabetes mellitus and have demonstrated clinical efficacy in treating certain skin conditions.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2007.03273.x","type":"journal-article","created":{"date-parts":[[2007,6,6]],"date-time":"2007-06-06T04:32:50Z","timestamp":1181104370000},"page":"557-563","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Thiazolidinediones in dermatology"],"prefix":"10.1111","volume":"46","author":[{"given":"Alan S.","family":"Boyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,5]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06369.x"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.10.1304"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01861.x"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/347645a0"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050345"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2005.02504.x"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041001"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aia.0000157485.91241.0b"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200310000-00003"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.5.609"},{"key":"e_1_2_10_12_2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1158\/1535-7163.1249.3.10","article-title":"Peroxisome proliferators\u2010activated receptor \u03b3 and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias","volume":"3","author":"Konopleva M","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.5-5-361"},{"key":"e_1_2_10_14_2","first-page":"649","article-title":"A new rexinoid for cutaneous T\u2010cell lymphoma","volume":"137","author":"Cheng SX","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.6.3406"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2005.04434.x"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.5.4932"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.2.405"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23235.x"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068897"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000004523.51779.7c"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh423"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20574"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.4.1626"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.52.299"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590500231627"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.13.9116"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215634"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11775"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.12.1504"},{"key":"e_1_2_10_31_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","article-title":"Rosiglitazone in the treatment of HAART\u2010associated lipodystrophy: a randomized double\u2010blind placebo\u2010controlled study","volume":"8","author":"Sutinen J","year":"2003","journal-title":"Antivir Ther"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08094-7"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-10-200405180-00008"},{"key":"e_1_2_10_34_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2337\/diab.47.1.98","article-title":"Depot\u2010specific differences in adipose tissue gene expression in lean and obese subject","volume":"47","author":"Lefebvre AM","year":"1998","journal-title":"Diabetes"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200210010-00006"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-4-200008150-00009"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2003.01034.x"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01757.x"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg076"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004330050123"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200502000-00005"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000062885.61917.A5"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15489-5"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200303280-00022"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-5-200509060-00009"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00758-5"},{"key":"e_1_2_10_47_2","first-page":"655","article-title":"Pioglitazone\u2010induced myofibroblast cell death: implications for cutaneous scarring","volume":"149","author":"O\u2019Leary R","year":"2003","journal-title":"Br J Dermatol"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202X.2003.22111.x"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2007.03273.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2007.03273.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:45:39Z","timestamp":1697355939000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2007.03273.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1111\/j.1365-4632.2007.03273.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2007.03273.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"2007-06-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}